Advances in molecular biology diagnostic and treatment of B-cell malignancies: indolent B-cell lymphoma.
Dreyling
M
M
Department of Internal Medicine III, Grosshadern Hospital, Ludwig-Maximilians University, Munich, Germany.
Buske
C
C
Hiddemann
W
W
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D016393:Lymphoma, B-Cell / Q000175:diagnosis* / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy*; D011379:Prognosis; D000069283:Rituximab; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab